MARATTO

article · The Egyptian Journal of Surgery

Postoperative outcomes of hepaticojejunostomy for benign biliary diseases.

2024Open accessSuez Canal University

Abstract

Background: Roux-en-Y hepaticojejunostomy (RYHJ) is currently considered the definitive treatment for iatrogenic bileduct injuries. This work aimed to assess the medical indications for HJ and analyze the postoperative complications of HJ.Patients and Methods: This prospective observational was conducted on 33 patients who underwent HJ for variousbenign diseases. The patients were divided into two groups: Patients with complications (n=19) and no complicationsgroup (n=14).Results: Patients with complications had a longer mean hospital stay and a higher average blood loss compared with those without complications. The logistic regression analysis identifies several variables potentially impacting the likelihood of postoperative complications, though none achieve statistical significance under the traditional P value threshold of 0.05. Age (P=0.075) and diabetes (P=0.078) approach significance, suggesting their possible influence on complication rates.Conclusion: Our study concluded that age and diabetes demonstrate higher associations with complication rates. Chestinfections is the most common postoperative complication. In the group with complications exhibited elevated bilirubinlevels greater than 2 mg/dl.

Research topics

  • Pediatric Hepatobiliary Diseases and Treatments
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Gallbladder and Bile Duct Disorders

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/ejsur.2024.286801.1063

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.